PROMETAX 4,6 mg/24 H PARCHE TRANSDERMICO
PROMETAX 4,6 mg/24 H PARCHE TRANSDERMICO
Commercialized
Register Number
98092021
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Dec 17, 2007
Dosage Form
PARCHE TRANSDÉRMICO
Route: VÍA TRANSDÉRMICA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number98092021
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RIVASTIGMINAActive
Quantity: 4,6 mg
Name: RIVASTIGMINA
ATC CLASSIFICATION (3)
N06D
N06DA
N06DA03